Cargando…

Biofabricated platinum nanoparticles: therapeutic evaluation as a potential nanodrug against breast cancer cells and drug-resistant bacteria

Use of plant extracts for the synthesis of various metal nanoparticles has gained much importance recently because it is a simple, less hazardous, conservative and cost-effective method. In this research work, platinum nanoparticles were synthesized by treating platinum ions with the leaf extract of...

Descripción completa

Detalles Bibliográficos
Autores principales: Manzoor, Saliha, Bashir, Dar Junaid, Imtiyaz, Khalid, Rizvi, M. Moshahid A., Ahamad, Irshad, Fatma, Tasneem, Agarwal, Nidhi Bharal, Arora, Indu, Samim, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036961/
https://www.ncbi.nlm.nih.gov/pubmed/35481013
http://dx.doi.org/10.1039/d1ra03133c
_version_ 1784693627911405568
author Manzoor, Saliha
Bashir, Dar Junaid
Imtiyaz, Khalid
Rizvi, M. Moshahid A.
Ahamad, Irshad
Fatma, Tasneem
Agarwal, Nidhi Bharal
Arora, Indu
Samim, Mohammed
author_facet Manzoor, Saliha
Bashir, Dar Junaid
Imtiyaz, Khalid
Rizvi, M. Moshahid A.
Ahamad, Irshad
Fatma, Tasneem
Agarwal, Nidhi Bharal
Arora, Indu
Samim, Mohammed
author_sort Manzoor, Saliha
collection PubMed
description Use of plant extracts for the synthesis of various metal nanoparticles has gained much importance recently because it is a simple, less hazardous, conservative and cost-effective method. In this research work, platinum nanoparticles were synthesized by treating platinum ions with the leaf extract of Psidium guajava and their structural properties were studied using various characterization techniques. The formation of platinum nanoparticles was confirmed by the disappearance of the absorbance peak at 261 nm in UV-visible spectra. The results of gas chromatography-mass spectrometry (GC-MS) and Fourier transform infrared spectroscopy (FT-IR) analysis showed functional moieties responsible for bio-reduction of metal ions and stabilization of platinum nanoparticles. The use of dynamic light scattering (DLS) imaging techniques confirmed the formation of stable monodispersed platinum nanoparticles showing a zeta potential of −23.4 mV. The morphological examination using high resolution transmission electron microscopy (HR-TEM) and Scanning electron microscopy (SEM) confirmed the formation of spherical platinum nanoparticles with an average diameter of 113.2 nm. X-ray powder diffraction (XRD) techniques showed the crystalline nature of biosynthesized platinum nanoparticles with a face-centered cubic structure. The results of energy-dispersive X-ray spectroscopy (EDAX) showed 100% platinum content by weight confirming the purity of the sample. The cytotoxic effect of biosynthesized platinum nanoparticles assessed in a breast cancer (MCF-7) cell-line by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, revealed an IC(50) of 167.2 μg ml(−1). The results of a wound healing assay showed that treatment with platinum nanoparticles induced an anti-migratory effect on MCF-7 cells. In the cell cycle phase distribution, treatment with platinum nanoparticles inhibited cell proliferation as determined by flow cytometry with PI staining. Significant cell cycle arrest was detected at the G0/G1 phase with a notable decrease in the distribution of cells in the S and G2/M phases. The anti-bacterial activity of bio-synthesized platinum nanoparticles was evaluated against four pathogenic bacteria i.e. B. cereus (Gram positive), P. aeruginosa (Gram negative), K. pneumonia (Gram negative) and E. coli (Gram negative). The biosynthesized platinum nanoparticles were found to show dose-dependent inhibition against pathogenic bacteria with a significant effect on Gram-negative bacteria compared to Gram-positive bacteria. This synergistic blend of green and simplistic synthesis coupled with anti-proliferative and anti-bacterial properties makes these biogenic nanoparticles suitable in nanomedicine.
format Online
Article
Text
id pubmed-9036961
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-90369612022-04-26 Biofabricated platinum nanoparticles: therapeutic evaluation as a potential nanodrug against breast cancer cells and drug-resistant bacteria Manzoor, Saliha Bashir, Dar Junaid Imtiyaz, Khalid Rizvi, M. Moshahid A. Ahamad, Irshad Fatma, Tasneem Agarwal, Nidhi Bharal Arora, Indu Samim, Mohammed RSC Adv Chemistry Use of plant extracts for the synthesis of various metal nanoparticles has gained much importance recently because it is a simple, less hazardous, conservative and cost-effective method. In this research work, platinum nanoparticles were synthesized by treating platinum ions with the leaf extract of Psidium guajava and their structural properties were studied using various characterization techniques. The formation of platinum nanoparticles was confirmed by the disappearance of the absorbance peak at 261 nm in UV-visible spectra. The results of gas chromatography-mass spectrometry (GC-MS) and Fourier transform infrared spectroscopy (FT-IR) analysis showed functional moieties responsible for bio-reduction of metal ions and stabilization of platinum nanoparticles. The use of dynamic light scattering (DLS) imaging techniques confirmed the formation of stable monodispersed platinum nanoparticles showing a zeta potential of −23.4 mV. The morphological examination using high resolution transmission electron microscopy (HR-TEM) and Scanning electron microscopy (SEM) confirmed the formation of spherical platinum nanoparticles with an average diameter of 113.2 nm. X-ray powder diffraction (XRD) techniques showed the crystalline nature of biosynthesized platinum nanoparticles with a face-centered cubic structure. The results of energy-dispersive X-ray spectroscopy (EDAX) showed 100% platinum content by weight confirming the purity of the sample. The cytotoxic effect of biosynthesized platinum nanoparticles assessed in a breast cancer (MCF-7) cell-line by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, revealed an IC(50) of 167.2 μg ml(−1). The results of a wound healing assay showed that treatment with platinum nanoparticles induced an anti-migratory effect on MCF-7 cells. In the cell cycle phase distribution, treatment with platinum nanoparticles inhibited cell proliferation as determined by flow cytometry with PI staining. Significant cell cycle arrest was detected at the G0/G1 phase with a notable decrease in the distribution of cells in the S and G2/M phases. The anti-bacterial activity of bio-synthesized platinum nanoparticles was evaluated against four pathogenic bacteria i.e. B. cereus (Gram positive), P. aeruginosa (Gram negative), K. pneumonia (Gram negative) and E. coli (Gram negative). The biosynthesized platinum nanoparticles were found to show dose-dependent inhibition against pathogenic bacteria with a significant effect on Gram-negative bacteria compared to Gram-positive bacteria. This synergistic blend of green and simplistic synthesis coupled with anti-proliferative and anti-bacterial properties makes these biogenic nanoparticles suitable in nanomedicine. The Royal Society of Chemistry 2021-07-16 /pmc/articles/PMC9036961/ /pubmed/35481013 http://dx.doi.org/10.1039/d1ra03133c Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Manzoor, Saliha
Bashir, Dar Junaid
Imtiyaz, Khalid
Rizvi, M. Moshahid A.
Ahamad, Irshad
Fatma, Tasneem
Agarwal, Nidhi Bharal
Arora, Indu
Samim, Mohammed
Biofabricated platinum nanoparticles: therapeutic evaluation as a potential nanodrug against breast cancer cells and drug-resistant bacteria
title Biofabricated platinum nanoparticles: therapeutic evaluation as a potential nanodrug against breast cancer cells and drug-resistant bacteria
title_full Biofabricated platinum nanoparticles: therapeutic evaluation as a potential nanodrug against breast cancer cells and drug-resistant bacteria
title_fullStr Biofabricated platinum nanoparticles: therapeutic evaluation as a potential nanodrug against breast cancer cells and drug-resistant bacteria
title_full_unstemmed Biofabricated platinum nanoparticles: therapeutic evaluation as a potential nanodrug against breast cancer cells and drug-resistant bacteria
title_short Biofabricated platinum nanoparticles: therapeutic evaluation as a potential nanodrug against breast cancer cells and drug-resistant bacteria
title_sort biofabricated platinum nanoparticles: therapeutic evaluation as a potential nanodrug against breast cancer cells and drug-resistant bacteria
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036961/
https://www.ncbi.nlm.nih.gov/pubmed/35481013
http://dx.doi.org/10.1039/d1ra03133c
work_keys_str_mv AT manzoorsaliha biofabricatedplatinumnanoparticlestherapeuticevaluationasapotentialnanodrugagainstbreastcancercellsanddrugresistantbacteria
AT bashirdarjunaid biofabricatedplatinumnanoparticlestherapeuticevaluationasapotentialnanodrugagainstbreastcancercellsanddrugresistantbacteria
AT imtiyazkhalid biofabricatedplatinumnanoparticlestherapeuticevaluationasapotentialnanodrugagainstbreastcancercellsanddrugresistantbacteria
AT rizvimmoshahida biofabricatedplatinumnanoparticlestherapeuticevaluationasapotentialnanodrugagainstbreastcancercellsanddrugresistantbacteria
AT ahamadirshad biofabricatedplatinumnanoparticlestherapeuticevaluationasapotentialnanodrugagainstbreastcancercellsanddrugresistantbacteria
AT fatmatasneem biofabricatedplatinumnanoparticlestherapeuticevaluationasapotentialnanodrugagainstbreastcancercellsanddrugresistantbacteria
AT agarwalnidhibharal biofabricatedplatinumnanoparticlestherapeuticevaluationasapotentialnanodrugagainstbreastcancercellsanddrugresistantbacteria
AT aroraindu biofabricatedplatinumnanoparticlestherapeuticevaluationasapotentialnanodrugagainstbreastcancercellsanddrugresistantbacteria
AT samimmohammed biofabricatedplatinumnanoparticlestherapeuticevaluationasapotentialnanodrugagainstbreastcancercellsanddrugresistantbacteria